Mounjaro®
Starting from £179.99/mo
Start journey Learn moreItching on Mounjaro can occur, and for most people it is mild and temporary. Tirzepatide itching is most commonly a localised skin reaction at the injection site, though some people notice more widespread itchiness. Rarely, itching is a sign of an allergic reaction that needs medical attention. Knowing which you are dealing with changes the decision you need to make. These are prescription-only medicines, and any new or persistent skin symptom is worth discussing with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the first question worth asking yourself, because the answer shapes everything else. Localised itching directly at or around the spot where you injected is very common with subcutaneous medicines. The needle creates a small wound, and the body's inflammatory response to that, combined with tirzepatide fluid absorbing into the tissue, can leave the skin itchy, slightly red, or mildly raised for a few hours. It usually settles on its own. Rotating injection sites between the abdomen, thigh, and upper arm helps considerably, because repeatedly injecting the same spot prevents the skin from recovering between doses.
If the itching is generalised, meaning it covers parts of your body well away from the injection, the picture is different. Some people notice a diffuse itchiness in the days after a new dose or a dose increase, which may reflect the way tirzepatide alters gut-hormone signalling and, in turn, skin physiology. This is not well characterised in the trial data, but it is reported by patients and is documented under the side-effects profile for GLP-1 receptor agonists. The NHS medicines page for tirzepatide lists skin reactions among the possible side effects and advises telling a doctor or pharmacist if they become troublesome. For a broader picture of what Mounjaro is and how it works in the body, our Mounjaro overview covers the dual GIP and GLP-1 mechanism in plain terms.
If you are unsure whether the itch is local or systemic, take a few minutes to note exactly where it is, when it started relative to your last injection, and whether it has spread. That information is exactly what a prescriber needs.
Most itching on Mounjaro does not require emergency action. There is, however, a pattern that does, and it is important to recognise it. Itching that arrives alongside hives (raised, blotchy welts on the skin), swelling of the face, lips, tongue, or throat, difficulty swallowing, or shortness of breath is consistent with a serious allergic reaction. This requires a 999 call or immediate attendance at an emergency department. Do not wait to see if it settles.
A milder allergic response, one with itching and a rash but no swelling or breathing difficulty, still needs same-day medical review. The distinction between a nuisance skin reaction and the early phase of a more serious allergy is not always obvious from the outside, which is why any skin change accompanied by other new symptoms should be assessed promptly. If you are a nume patient and you are unsure, our aftercare team is available seven days a week and can advise you on whether this warrants urgent care or a routine message to your prescriber. You can reach us through the contact page.
People who have a known history of severe allergic reactions should discuss this in their consultation before starting treatment, so the prescriber can factor it into their clinical assessment. Our prescribers review every patient personally (a real clinician reads your answers, not software) which is precisely the kind of nuance that matters when medicines interact with individual histories.
If your itch is localised and mild, a few straightforward steps can reduce it without needing to change your treatment. Let the pen warm to room temperature before injecting — a cold pen straight from the fridge can irritate the tissue. Inject slowly and hold the pen in place for the full count recommended in your Patient Information Leaflet. Clean the site beforehand with an alcohol swab and allow it to dry completely before injecting, because wet skin increases local reaction. After removing the pen, press gently on the site rather than rubbing, which can spread the medicine and worsen irritation.
Beyond injection technique, clothing choice matters more than people expect: tight waistbands sitting directly over abdominal injection sites throughout the day can prolong inflammation and itchiness. Loose-fitting clothes for the hours after a dose can make a real difference. Some patients also find that taking their weekly injection on a Friday or Saturday, when they are less likely to be in formal clothing, reduces discomfort, a small logistical detail that our prescribers sometimes suggest. Similarly, if payday or a holiday falls around your usual injection day and you want guidance on timing, your prescriber is the right person to ask rather than adjusting the schedule yourself.
You can read more about other unexpected physical symptoms some people notice on treatment, including aching legs on Mounjaro and eye twitching, which patients also ask about frequently. Understanding the full range of what can happen helps you decide when something warrants attention and when it is simply your body adjusting.
Mounjaro carries a Black Triangle (▼) designation in the UK, assigned by the MHRA to newer medicines where the regulator wants to build a comprehensive picture of real-world side effects beyond clinical trial populations. That designation makes your reports genuinely useful. If you experience itching or any other skin reaction on tirzepatide, you can log it directly at the MHRA's Yellow Card scheme, which accepts reports from patients as well as healthcare professionals. You do not need a prescriber to submit one on your behalf.
Keeping a brief record (date, dose, location of the itch, how long it lasted, what you tried) also helps your prescriber make an informed decision at your next review. Dose increases are a common trigger for new or worsened skin reactions, and that pattern is worth flagging early rather than after several weeks of discomfort. If you want a deeper look at why this happens, our page on whether Mounjaro makes you itch explains the mechanisms behind both localised and generalised skin reactions in more detail. Some patients also report sleep disturbances alongside skin symptoms, and our page covering nightmares on Mounjaro addresses that cluster of side effects for anyone who has noticed both at once. If itching is significantly affecting your day-to-day life, there is no clinical reason to tolerate it silently, and our guide to managing itchy skin on Mounjaro sets out the practical and clinical options available to you. Adjustments in how or when you inject, or in some cases a clinical conversation about titration pace, can make treatment more comfortable without compromising its effect. If you are considering whether Mounjaro or another licensed weight-loss treatment suits your situation, starting with a free consultation means a prescriber can review your full picture, including any skin sensitivities, before anything is prescribed. Check your eligibility to begin that process.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.